Sun Pharma gets CCI nod to sell two CNS divisions to Strides
Drug major Sun Pharma has received approval from competition watchdog CCI to sell the erstwhile Ranbaxy Laboratories' two divisions in the central nervous system (CNS) segment in India to Strides Shasun for Rs 165 crore.
Jan 22, 2016, 21:06 PM IST
Sun Pharma to sell Ranbaxy's 2 CNS divisions to Strides for Rs 165 crore
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.
Sep 19, 2015, 15:13 PM IST
